SCHEMBL23948433

SCHEMBL23948433

CC(C)CC(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
HBB P68871 2/20 0.52
MAPK1 P28482 1/20 0.52
PNP P00491 7/20 0.45
TSHR P16473 2/20 0.45
BLM P54132 2/20 0.45
USP2 O75604 1/20 0.45
EDNRA P25101 1/20 0.45
HTR2A P28223 1/20 0.45
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HPRT1 P00492 5/20 0.41
POLG P54098 1/20 0.41
PDE3A Q14432 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
NFKB1 P19838 1/20 0.37
VCP P55072 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valacyclovir SCHEMBL4295083 0.86 KMT2A (0.72) KMT2AMEN1HBBMAPK1PNP
Valacyclovir SCHEMBL34375 0.86 KMT2A (0.72) KMT2AMEN1HBBMAPK1PNP
Valacyclovir SCHEMBL29689659 0.85 HBB (0.72) KMT2AMEN1HBBMAPK1PNP
Valacyclovir SCHEMBL1888797 0.84 KMT2A (0.69) KMT2AMEN1HBBMAPK1PNP
SCHEMBL19236311 0.82 PDE3A (0.56) KMT2AMEN1HBBMAPK1PNP
Acyclovir SCHEMBL40723 0.80 PNP (0.67) KMT2AMEN1HBBMAPK1PNP
SCHEMBL15655101 0.78 MEN1 (0.45) KMT2AMEN1HBBMAPK1PNP
SCHEMBL4295065 0.78 MEN1 (0.45) KMT2AMEN1HBBMAPK1PNP
SCHEMBL1477723 0.78 PNP (0.61) KMT2AMEN1HBBMAPK1PNP
SCHEMBL4295075 0.77 KMT2A (0.48) KMT2AMEN1HBBMAPK1PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021209563-A1 COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY RESPIRATORY SYNDROME-RELATED CORONAVIRUS SOM INNOVATION BIOTECH, S.A. (ES) 2021-10-21 WO disclosed